DoW Ovarian Cancer, Clinical Trial Award
DoW Ovarian Cancer, Clinical Trial Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 01 Oct 2026. Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents…
Opportunity overview
- Project name
- DoW Ovarian Cancer, Clinical Trial Award
- Donor
- Defense Health Agency Contracting Activity - DHACA
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is DoW Ovarian Cancer, Clinical Trial Award?
DoW Ovarian Cancer, Clinical Trial Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 01 Oct 2026. Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents…
Who is funding DoW Ovarian Cancer, Clinical Trial Award?
DoW Ovarian Cancer, Clinical Trial Award is funded by Defense Health Agency Contracting Activity - DHACA.
When is the deadline to apply for DoW Ovarian Cancer, Clinical Trial Award?
The application deadline is 01 Oct 2026 00:00 (UTC).
Where will the DoW Ovarian Cancer, Clinical Trial Award project take place?
The project location(s) are: United States.
How can I apply for DoW Ovarian Cancer, Clinical Trial Award?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.